Feasibility and safety of intrathecal treatment with nusinersen in adult patients with spinal muscular atrophy-Reference-Cited by-同舟云学术

Feasibility and safety of intrathecal treatment with nusinersen in adult patients with spinal muscular atrophy

Published:2018-01 Issue: Volume:11 Page:175628641880324
ISSN:1756-2864
Container-title:Therapeutic Advances in Neurological Disorders
language:en
Short-container-title:Ther Adv Neurol Disord

Author:

Stolte Benjamin¹,Totzeck Andreas¹,Kizina Kathrin¹,Bolz Saskia¹,Pietruck Lena¹,Mönninghoff Christoph²,Guberina Nika²,Oldenburg Denise²,Forsting Michael²,Kleinschnitz Christoph¹,Hagenacker Tim³

Affiliation:

1. Department of Neurology, University Hospital Essen, Essen, Germany

2. Department of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, Essen, Germany

3. Department of Neurology, University Hospital Essen, Hufelandstr.55, Essen, 45147, Germany

Publisher

SAGE Publications

Subject

Neurology (clinical),Neurology,Pharmacology

Link

http://journals.sagepub.com/doi/pdf/10.1177/1756286418803246

Reference29 articles.

1. Childhood spinal muscular atrophy: controversies and challenges

2. Pan-ethnic carrier screening and prenatal diagnosis for spinal muscular atrophy: clinical laboratory analysis of >72 400 specimens

3. Spinal muscular atrophy

4. A collaborative study on the natural history of childhood and juvenile onset proximal spinal muscular atrophy (type II and III SMA): 569 patients

Cited by 65 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lumbar Transforaminal Injections of Nusinersen in Spinal Muscular Atrophy Patients;Neuroimaging Clinics of North America;2024-09

2. Nusinersen Improves Motor Function in Type 2 and 3 Spinal Muscular Atrophy Patients across Time;Biomedicines;2024-08-06

3. Improvement in functional motor scores in patients with non-ambulatory spinal muscle atrophy during Nusinersen treatment in South Korea: a single center study;BMC Neurology;2024-06-20

4. A real-world pharmacovigilance study of nusinersen based on the FAERS database;2024-06-13

5. Switching from Nusinersen to Risdiplam: A Croatian Real-World Experience on Effectiveness and Safety;Journal of Personalized Medicine;2024-02-24